You are viewing an incomplete version of our website. Please click to reload the website as full version.

serine/threonine Kinase 17b (STK17B) (C-Term) Peptide

Details for Product No. ABIN1382031, Supplier: Login to see
Protein Name
  • zgc:65989
  • STK17B
  • DRAK2
  • Drak2
  • 3110009A03Rik
  • AI120141
Protein Region
C-Term
Origin
Human
5
2
2
2
Application
Blocking Peptide (BP)
Supplier
Login to see
Supplier Product No.
Login to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Blocked Antibody anti-serine/threonine Kinase 17b (STK17B) (C-Term) antibody (ABIN1030368)
Characteristics 15 amino acids near the carboxy terminus of human DRAK2.
Human
Research Area Signaling, Apoptosis/Necrosis
Application Notes DRAK2 peptide is used for blocking the activity of DRAK2.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Sanjo, Kawai, Akira: "DRAKs, novel serine/threonine kinases related to death-associated protein kinase that trigger apoptosis." in: The Journal of biological chemistry, Vol. 273, Issue 44, pp. 29066-71, 1998 (PubMed).